A medical student is studying transmission through autonomicganglia. She studied the effects of two drugs on the activityof a postganglionic neuron. Drug A induced an EPSP in thepostganglionic neuron, and drug B blocked the EPSP producedby electrical stimulation of a preganglionic nerve. Drugs A and Bmight be the following drugs, respectively.A. Glutamate and glycineB. Nicotine and atropineC. Strychnine and atenololD. Nicotine and trimethaphanE. Acetylcholine and phenylephrine

To determine which drugs A and B might be, let's analyze the effects described:

1. Drug A induced an EPSP (excitatory postsynaptic potential) in the postganglionic neuron.

   • This suggests that Drug A is likely a substance that mimics or enhances the action of a neurotransmitter that causes excitation in the postganglionic neuron.

2. Drug B blocked the EPSP produced by electrical stimulation of a preganglionic nerve.

   • This suggests that Drug B is likely an antagonist that blocks the action of the neurotransmitter responsible for the EPSP.

Now, let's evaluate each option:

A. Glutamate and glycine

• Glutamate is an excitatory neurotransmitter, but it is primarily involved in the central nervous system, not typically in autonomic ganglia.
• Glycine is an inhibitory neurotransmitter, not an antagonist that would block an EPSP in autonomic ganglia.
• This option is unlikely.

B. Nicotine and atropine

• Nicotine is an agonist at nicotinic acetylcholine receptors, which are found in autonomic ganglia and can induce an EPSP.
• Atropine is an antagonist at muscarinic acetylcholine receptors, not nicotinic receptors. Therefore, it would not block the EPSP in autonomic ganglia.
• This option is unlikely.

C. Strychnine and atenolol

• Strychnine is an antagonist of glycine receptors, which are inhibitory, not excitatory.
• Atenolol is a beta-blocker, which affects adrenergic receptors, not typically involved in the initial EPSP in autonomic ganglia.
• This option is unlikely.

D. Nicotine and trimethaphan

• Nicotine, as mentioned, is an agonist at nicotinic acetylcholine receptors and can induce an EPSP in autonomic ganglia.
• Trimethaphan is a ganglionic blocker that blocks nicotinic acetylcholine receptors in autonomic ganglia, thus preventing the EPSP.
• This option is likely.

E. Acetylcholine and phenylephrine

• Acetylcholine is the natural neurotransmitter that acts on nicotinic receptors in autonomic ganglia to induce an EPSP.
• Phenylephrine is an alpha-adrenergic agonist, which does not block nicotinic receptors and would not prevent the EPSP.
• This option is unlikely.

Based on the analysis, the most likely answer is:

D. Nicotine and trimethaphan